Urinary connective tissue growth factor is associated with human renal allograft fibrogenesis

Transplantation

Volumn 96, Issue 5, 2013, Pages 494-500

  Metalidis, Christoph ^a   Van Vuuren, Stefan H ^b   Broekhuizen, Roel ^b   Lerut, Evelyne ^a   Naesens, Maarten ^a   Bakker, Stephan J L ^c   Wetzels, Jack F M ^d   Goldschmeding, Roel ^b   Kuypers, Dirk R J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic allograft injury; Connective tissue growth factor; Fibrosis; Kidney transplantation

Indexed keywords

BIOLOGICAL MARKER; CONNECTIVE TISSUE GROWTH FACTOR;

ADULT; ARTICLE; CADAVER DONOR; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIBROGENESIS; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; URINALYSIS;

ADULT; AGED; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84883560871     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31829b07e1     Document Type: Article

References (30)

1. Nankivell BJ, Kuypers DR. Diagnosis and prevention of chronic kidney allograft loss. Lancet 2011; 378: 1428
2. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004; 4: 1289
3. McDonald S, Russ G, Campbell S, et al. Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcome. Am J Transplant 2007; 7: 1201
4. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199
5. Bradham DM, Igarashi A, Potter RL, et al. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991; 114: 1285
6. de Winter P, Leoni P, Abraham D. Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors 2008; 26: 80
7. Arnott JA, Nuglozeh E, Rico MC, et al. Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF-beta1- induced extracellular matrix production in osteoblasts. J Cell Physiol 2007; 210: 843
8. Gressner OA, Lahme B, Demirci I, et al. Differential effects of TGFbeta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol 2007; 47: 699
9. Higgins DF, Biju MP, Akai Y, et al. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 2004; 287: F1223
10. Hishikawa K, Oemar BS, Nakaki T. Static pressure regulates connective tissue growth factor expression in human mesangial cells. J Biol Chem 2001; 276: 16797
11. Finckenberg P, Inkinen K, Ahonen J, et al. Angiotensin II induces connective tissue growth factor gene expression via calcineurindependent pathways. Am J Pathol 2003; 163: 355
12. Kunzmann S, Seher A, Kramer BW, et al. Connective tissue growth factor does not affect transforming growth factor-beta1-induced Smad3 phosphorylation and T lymphocyte proliferation inhibition. Int Arch Allergy Immunol 2008; 147: 152
13. Allen JT, Knight RA, Bloor CA, et al. Enhanced insulin-like growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1999; 21: 693
14. Cicha I, Garlichs CD, DanielWG, et al. Activated human platelets release connective tissue growth factor. Thromb Haemost 2004; 91: 755
15. Igarashi A, Nashiro K, Kikuchi K, et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 1996; 106: 729
16. Ito Y, Aten J, Bende RJ, et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998; 53: 853
17. Mizutani M, Ito Y, Mizuno M, et al. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol 2010; 298: F721
18. Paradis V, Dargere D, Vidaud M, et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999; 30: 968
19. Cheng O, Thuillier R, Sampson E, et al. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant 2006; 6: 2292
20. Shi Y, Tu Z, Bao J, et al. Urinary connective tissue growth factor increases far earlier than histopathological damage and functional deterioration in early chronic renal allograft injury. Scand J Urol Nephrol 2009; 43: 390
21. Luo GH, Lu YP, Song J, et al. Inhibition of connective tissue growth factor by small interfering RNA prevents renal fibrosis in rats undergoing chronic allograft nephropathy. Transplant Proc 2008; 40: 2365
22. Yokoi H, Mukoyama M, Sugawara A, et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol 2002; 282: F933
23. Gerritsen KG, Peters HP, Nguyen TQ, et al. Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion. Am J Physiol Renal Physiol 2010; 298: F1457
24. Nguyen TQ, Tarnow L, Andersen S, et al. Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006; 29: 83
25. Grotendorst GR, Rahmanie H, Duncan MR. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 2004; 18: 469
26. Kuypers DR, de JH, Naesens M, et al. CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients. Clin Pharmacol Ther 2007; 82: 711
27. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713
28. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteriaVan addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708
29. Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant 2004; 4: 1562
30. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461.